Forwarded from Ophthalmology Books (🅰AHMED😎FOUAD📚)
Please open Telegram to view this post
VIEW IN TELEGRAM
Forwarded from Ophthalmology Books (🅰AHMED😎FOUAD📚)
Please open Telegram to view this post
VIEW IN TELEGRAM
https://www.nature.com/articles/s41588-019-0556-y
https://sci-hub.si/https://www.nature.com/articles/s41588-019-0556-y
https://sci-hub.si/https://www.nature.com/articles/s41588-019-0556-y
Nature
Multitrait analysis of glaucoma identifies new risk loci and enables polygenic prediction of disease susceptibility and progression
Nature Genetics - Multitrait genome-wide analysis of glaucoma and related phenotypes identifies new risk loci and enables development of a polygenic risk score to predict disease susceptibility and...
https://onlinelibrary.wiley.com/doi/abs/10.1111/aos.14283
https://sci-hub.si/https://onlinelibrary.wiley.com/doi/abs/10.1111/aos.14283
https://sci-hub.si/https://onlinelibrary.wiley.com/doi/abs/10.1111/aos.14283
Wiley Online Library
Safety of soft contact lenses in children: retrospective review of six randomized controlled trials of myopia control
Purpose
To examine the rate and types of ocular adverse events among children wearing soft contact lenses.
Methods
This study is a retrospective review of ocular adverse event data from six random...
To examine the rate and types of ocular adverse events among children wearing soft contact lenses.
Methods
This study is a retrospective review of ocular adverse event data from six random...
https://www.nejm.org/doi/full/10.1056/NEJMoa1910434
https://sci-hub.si/https://www.nejm.org/doi/full/10.1056/NEJMoa1910434
https://sci-hub.si/https://www.nejm.org/doi/full/10.1056/NEJMoa1910434
The New England Journal of Medicine
Teprotumumab for the Treatment of Active Thyroid Eye Disease | NEJM
Thyroid eye disease is a debilitating, disfiguring, and potentially blinding periocular
condition for which no Food and Drug Administration–approved medical therapy is available.
Strong evidence ha...
condition for which no Food and Drug Administration–approved medical therapy is available.
Strong evidence ha...
Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)32981-2/fulltext
https://sci-hub.si/https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)32981-2/fulltext
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)32981-2/fulltext
https://sci-hub.si/https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)32981-2/fulltext
https://bjo.bmj.com/content/104/2/153?utm_source=alert&utm_medium=email&utm_campaign=bjo&utm_content=toc&utm_term=22012020
https://sci-hub.si/https://bjo.bmj.com/content/104/2/153?utm_source=alert&utm_medium=email&utm_campaign=bjo&utm_content=toc&utm_term=22012020
https://sci-hub.si/https://bjo.bmj.com/content/104/2/153?utm_source=alert&utm_medium=email&utm_campaign=bjo&utm_content=toc&utm_term=22012020
British Journal of Ophthalmology
Controversies on neuroprotection therapy in non-arteritic anterior ischaemic optic neuropathy
Objective There has long been a great interest in neuroprotection therapy for ischaemic stroke and various types of optic neuropathies. In view of that, I reviewed the literature on the role of neuroprotection for non-arteritic anterior ischaemic optic neuropathy…
https://bjo.bmj.com/content/104/1/81?utm_source=alert&utm_medium=email&utm_campaign=bjo&utm_content=toc&utm_term=12122019
https://sci-hub.si/https://bjo.bmj.com/content/104/1/81?utm_source=alert&utm_medium=email&utm_campaign=bjo&utm_content=toc&utm_term=12122019
https://sci-hub.si/https://bjo.bmj.com/content/104/1/81?utm_source=alert&utm_medium=email&utm_campaign=bjo&utm_content=toc&utm_term=12122019
British Journal of Ophthalmology
Risk factors for disease progression in low-teens normal-tension glaucoma
Background/Aims To investigate the risk factors for disease progression of normal-tension glaucoma (NTG) with pretreatment intraocular pressure (IOP) in the low-teens.
Methods One-hundred and two (102) eyes of 102 patients with NTG with pretreatment IOP≤12…
Methods One-hundred and two (102) eyes of 102 patients with NTG with pretreatment IOP≤12…
https://bjo.bmj.com/content/104/1/92?utm_source=alert&utm_medium=email&utm_campaign=bjo&utm_content=toc&utm_term=12122019
https://sci-hub.si/https://bjo.bmj.com/content/104/1/92?utm_source=alert&utm_medium=email&utm_campaign=bjo&utm_content=toc&utm_term=12122019
https://sci-hub.si/https://bjo.bmj.com/content/104/1/92?utm_source=alert&utm_medium=email&utm_campaign=bjo&utm_content=toc&utm_term=12122019
British Journal of Ophthalmology
Volumetric parameters-based differentiation of narrow angle from open angle and classification of angle configurations: an SS-OCT…
Background To evaluate the diagnostic ability of volumetric parameters to differentiate narrow angle from open angle and distinguish different configurations of narrow angle.
Methods The current study was composed of two parts. In the first part, with gonioscopy…
Methods The current study was composed of two parts. In the first part, with gonioscopy…
https://bjo.bmj.com/content/104/1/104?utm_source=alert&utm_medium=email&utm_campaign=bjo&utm_content=toc&utm_term=12122019
https://sci-hub.si/https://bjo.bmj.com/content/104/1/104?utm_source=alert&utm_medium=email&utm_campaign=bjo&utm_content=toc&utm_term=12122019
https://sci-hub.si/https://bjo.bmj.com/content/104/1/104?utm_source=alert&utm_medium=email&utm_campaign=bjo&utm_content=toc&utm_term=12122019
British Journal of Ophthalmology
Topographic correlation between macular superficial microvessel density and ganglion cell-inner plexiform layer thickness in glaucoma…
Background/Aims To investigate the topographic relationship between macular superficial microvessel density (SMD) and macular ganglion cell-inner plexiform layer (GCIPL) thickness in eyes with glaucoma-suspect (GS) and early normal-tension glaucoma (NTG).…
https://bjo.bmj.com/content/early/2019/10/22/bjophthalmol-2019-315016
https://sci-hub.si/https://bjo.bmj.com/content/early/2019/10/22/bjophthalmol-2019-315016
https://sci-hub.si/https://bjo.bmj.com/content/early/2019/10/22/bjophthalmol-2019-315016
British Journal of Ophthalmology
Glaucoma management in the era of artificial intelligence
Glaucoma is a result of irreversible damage to the retinal ganglion cells. While an early intervention could minimise the risk of vision loss in glaucoma, its asymptomatic nature makes it difficult to diagnose until a late stage. The diagnosis of glaucoma…
https://www.nature.com/articles/s41433-019-0603-z?utm_source=eye_etoc&utm_medium=email&utm_campaign=toc_41433_34_1&utm_content=20191217&WT.ec_id=EYE-201912&sap-outbound-id=CC9B2D349F4D2231EAF10AE52BE63C031205B09D
https://sci-hub.si/https://www.nature.com/articles/s41433-019-0603-z?utm_source=eye_etoc&utm_medium=email&utm_campaign=toc_41433_34_1&utm_content=20191217&WT.ec_id=EYE-201912&sap-outbound-id=CC9B2D349F4D2231EAF10AE52BE63C031205B09D
https://sci-hub.si/https://www.nature.com/articles/s41433-019-0603-z?utm_source=eye_etoc&utm_medium=email&utm_campaign=toc_41433_34_1&utm_content=20191217&WT.ec_id=EYE-201912&sap-outbound-id=CC9B2D349F4D2231EAF10AE52BE63C031205B09D
Eye
A review of systemic medications that may modulate the risk of glaucoma
A review of systemic medications that may modulate the risk of glaucoma